首页|中药封包辅助治疗对慢性阻塞性肺疾病急性加重期BODE指数的临床观察

中药封包辅助治疗对慢性阻塞性肺疾病急性加重期BODE指数的临床观察

扫码查看
目的:观察中药封包辅助对慢性阻塞性肺疾病急性加重期BODE指数的治疗效果.方法:选取 2022 年 1月至 2023 年 3 月江西中医药大学第二附属医院呼吸内科接受诊治的慢性阻塞性肺疾病急性加重期患者 60 例为临床研究,按照随机数字排列表法分为西医治疗组和中药封包治疗组,每组 30 例.西医治疗组采取常规治疗,中药封包治疗组在西医治疗组基础上采取中药封包辅助治疗.观察两组肺功能指标、诊治前后 6 min步行距离(6MWD)、呼吸困难程度、体质量指数(BMI)变化及诊治效果.结果:中药封包治疗组 0 级呼吸困难发生率高于西医治疗组,3 级、4 级呼吸困难发生率显著低于西医治疗组(P<0.05);治疗前两组用力肺活量(FVC)占预计值百分比(FVC%pred)、第 1 秒钟用力呼气容积占用力肺活量百分比(FEV1/FVC)指标对比,差异无统计学意义(P>0.05);治疗后中药封包治疗组肺功能各指标均高于西医治疗组(P<0.05);治疗前两组 6MWD、BMI指标对比,差异无统计学意义(P>0.05);治疗后中药封包治疗组 6MWD、BMI 指标高于西医治疗组(P<0.05);中药封包治疗组治疗总有效率(93.33%)高于西医治疗组(66.67%)(P<0.05).结论:对慢性阻塞性肺疾病急性加重期患者进行中药封包辅助治疗,可提高治疗总有效率,有利于改善肺功能指标,缓解呼吸困难程度,提高 6MWD、BMI指标.
Clinical Observation on BODE Index During Acute Exacerbation of Chronic Obstructive Pulmonary Disease by Adjuvant Treatment with Chinese Medicine Seal Pack
Objective:To observe the effect of chinese herbal medicine encapsulation assisted treatment of BODE index during acute exacerbation of chronic obstructive pulmonary disease.Methods:Sixty patients with acute exacerbation of chronic obstructive pulmonary disease who were treated in the department of respiratory medicine of the second affiliated hospital of Jiangxi university of chinese medicine from January 2021 to March 2023 were selected for the clinical study,and they were divided into western medicine treatment group and chinese herbal medicine package treatment group according to the random number arrangement table.The patients in the western medicine treatment group were treated conventionally,and the patients in the chinese herbal medicine package treatment group were treated with the aid of chinese herbal medicine sealing package on the basis of the western medicine treatment group.The changes of pulmonary function index,6-minute walking distance(6MWD),dyspnea index,body mass index(BMI)and treatment effect of the two groups were observed and analyzed.The incidence of grade 0 dyspnea was higher in the chinese medicine packet treatment group compared with the western medicine treatment group,and the incidence of grade 3 and 4 dyspnea was significantly lower than that of the western medicine treatment group(P<0.05);There was no significant difference in FVC%pred and FEV1/FVC indexes between the two groups before treatment(P>0.05).After treatment,the indexes of lung function in the chinese herbal medicine package treatment group were higher than those in the western medicine treatment group(P<0.05).There was no significant difference in 6MWD and BMI between the two groups before treatment(P>0.05).After treatment,the 6MWD and BMI indexes of chinese herbal medicine package treatment group were higher than those of western medicine treatment group(P<0.05).The total effective rate of chinese herbal medicine package treatment group(93.33%)was higher than that of western medicine treatment group(66.67%)(P<0.05).Conclusion:Chinese medicine encapsulation assisted treatment for patients with acute exacerbation of chronic obstructive pulmonary disease can improve the total effective rate,improve lung function indexes,alleviate dyspnea,and increase 6MWD and BMI indexes.

Chronic obstructive pulmonary diseaseAcute exacerbation periodChinese medicine sealingBODE index

刘美年、刘敏、晁丹、丰巧微、吴娥

展开 >

江西中医药大学第二附属医院 南昌 330012

江西中医药大学附属医院 南昌 330006

慢性阻塞性肺疾病 急性加重期 中药封包 BODE指数

江西省中医药管理局科技计划项目

2021B285

2024

实用中西医结合临床
江西省中医药研究院,江西省中西医结合学会

实用中西医结合临床

影响因子:0.522
ISSN:1671-4040
年,卷(期):2024.24(1)
  • 25